BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1372221)

  • 1. Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.
    Bryson HM; Goa KL
    Drugs; 1992 Feb; 43(2):236-58. PubMed ID: 1372221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
    Palmer KJ; Holliday SM; Brogden RN
    Drugs; 1993 Mar; 45(3):430-75. PubMed ID: 7682911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mefloquine and halofantrine, new therapeutic drugs of malaria].
    Le Bras J; Ringwald P; Monsérié C; Basco LK
    Rev Med Interne; 1991; 12(1):68-74. PubMed ID: 2041918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type RI resistance to halofantrine in West Africa.
    Basco LK; Le Bras J; Gillotin C; Ringwald P; Rabenjarson E; Gimenez F; Bouchaud O; Farinotti R; Coulaud JP
    Trop Med Parasitol; 1991 Dec; 42(4):413-4. PubMed ID: 1665577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemotherapy of rodent malaria. XLII. Halofantrine and halofantrine resistance.
    Peters W; Robinson BL; Ellis DS
    Ann Trop Med Parasitol; 1987 Oct; 81(5):639-46. PubMed ID: 3331253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halofantrine for the treatment of mefloquine chemoprophylaxis failures in Plasmodium falciparum infections.
    Shanks GD; Watt G; Edstein MD; Webster HK; Suriyamongkol V; Watanasook C; Panpunnung S; Kowinwiphat W
    Am J Trop Med Hyg; 1991 Oct; 45(4):488-91. PubMed ID: 1951857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cross resistance to mefloquine and halofantrine in a case of P. falciparum malaria contracted in Sierra Leone].
    Félix R; Gay F; Lyogoubi A; Bustos MD; Diquet B; Danis M; Gentilini M
    Bull Soc Pathol Exot; 1990; 83(1):43-5. PubMed ID: 2190703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand.
    Bunnag D; Viravan C; Karbwang J; Looareesuwan S; Chittamas S; Harinasuta T; Serville P; Horton J
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):43-8. PubMed ID: 8362305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand.
    Boudreau EF; Pang LW; Dixon KE; Webster HK; Pavanand K; Tosingha L; Somutsakorn P; Canfield CJ
    Bull World Health Organ; 1988; 66(2):227-35. PubMed ID: 3293828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa).
    Ouédraogo JB; Dutheil Y; Tinto H; Traoré B; Zampa H; Tall F; Coulibaly SO; Guiguemdé TR
    Trop Med Int Health; 1998 May; 3(5):381-4. PubMed ID: 9623943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of halofantrine.
    Karbwang J; Na Bangchang K
    Clin Pharmacokinet; 1994 Aug; 27(2):104-19. PubMed ID: 7955774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerance of extended-dose halofantrine for drug-resistant falciparum malaria in Thailand.
    Watt G; Loesuttiviboon L; Jongsakul K; Shanks GD; Ohrt CK; Karnasuta C; Schuster B; Fleckenstein L
    Am J Trop Med Hyg; 1994 Feb; 50(2):187-92. PubMed ID: 8116811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Plasmodium falciparum to four antimalarial drugs in the Central Province of Papua New Guinea.
    Hombhanje FW
    P N G Med J; 1998 Jun; 41(2):51-8. PubMed ID: 10934544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview: clinical pharmacology of antimalarials.
    Karbwang J; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():95-109. PubMed ID: 1364873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of radical treatment with halofantrine on the prevention of imported Plasmodium falciparum malaria].
    Baudon D; Bernard J; Mouliat-Pelat JP; Martet G; Sarrouy J; Touzé JE; Spiegel A; Lantrade P; Picq JJ
    Ann Soc Belg Med Trop; 1992 Dec; 72(4):263-70. PubMed ID: 1292422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.